The tyrosine phosphatase inhibitor vanadate protects osteoblasts from growth inhibition by glucocorticoids.
Asıl Yazarlar: | Hulley, P, Conradie, R, Titus, C, Hough, F |
---|---|
Materyal Türü: | Journal article |
Baskı/Yayın Bilgisi: |
1999
|
Benzer Materyaller
-
Vanadate protects osteoblasts in vitro and in vivo from glucocorticoid impairment of proliferation
Yazar:: Hulley, P, ve diğerleri
Baskı/Yayın Bilgisi: (2002) -
Pathogenesis of glucocorticoid osteoporosis: Role of tyrosine phosphatases
Yazar:: Hulley, P, ve diğerleri
Baskı/Yayın Bilgisi: (2001) -
Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo.
Yazar:: Conradie, M, ve diğerleri
Baskı/Yayın Bilgisi: (2007) -
Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate.
Yazar:: Hulley, P, ve diğerleri
Baskı/Yayın Bilgisi: (2002) -
Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.
Yazar:: Horsch, K, ve diğerleri
Baskı/Yayın Bilgisi: (2007)